FR901464
(1) and spliceostatin A (2)
are potent inhibitors of spliceosomes. These compounds have shown
remarkable anticancer activity against multiple human cancer cell
lines. Herein, we describe efficient, enantioselective syntheses of
FR901464, spliceostatin A, six corresponding diastereomers and an
evaluation of their splicing activity. Syntheses of spliceostatin
A and FR901464 were carried out in the longest linear sequence of
9 and 10 steps, respectively. To construct the highly functionalized
tetrahydropyran A-ring, we utilized
CBS reduction, Achmatowicz rearrangement, Michael addition, and reductive
amination as key steps. The remarkable diastereoselectivity of the
Michael addition was specifically demonstrated with different substrates
under various reaction conditions. The side chain B was prepared from an optically active alcohol, followed
by acetylation and hydrogenation over Lindlar’s catalyst. The
other densely functionalized tetrahydropyran C-ring was derived from readily available (R)-isopropylidene glyceraldehyde through a route featuring 1,2-addition,
cyclic ketalization, and regioselective epoxidation. These fragments
were coupled together at a late stage through amidation and cross-metathesis
in a convergent manner. Six key diastereomers were then synthesized
to probe the importance of specific stereochemical features of FR901464
and spliceostatin A, with respect to their in vitro splicing activity.